Cell Bio-Systems Pursuing Medical Device Research Grants.SAN DIEGO -- Cell Bio-Systems Inc. (Pink Sheets:CBSI CBSI CUNA Brokerage Services, Inc. CBSI Cambodian Buddhist Society, Inc. (Silver Springs, Maryland) CBSI Certified Bridge Safety Inspector CBSI Custom Business Solutions, Inc. ), a biotechnology company positioned to manufacture and distribute patented, disposable technologies for stem cell stem cell In living organisms, an undifferentiated cell that can produce other cells that eventually make up specialized tissues and organs. There are two major types of stem cells, embryonic and adult. research, cosmetic surgery cosmetic surgery, plastic surgery for cosmetic purposes, such as the improvement of the appearance of the face by removing wrinkles or reshaping the nose. and other living tissue procedures, announced today that it is applying for a Medical Device Research Grant from the Federal Government. Marc Pilkington, the President of Cell Bio-Systems, stated, "The funds the Company receives through grants such as the Medical Device Research Grant, which we are currently applying for, allow us to develop instrumentation that will be key in future advancements in stem cell technology." In working with delicate tissue at a cellular level the instrumentation becomes more important than ever before. Developing instrumentation to improve the outcome in the management of stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young is basic and crucial to the success of these advanced procedures. These procedures range from research being done in lab to full blown therapeutics developed from this research. Mr. Pilkington noted that it is expensive to develop new technology in medical devices and the grants being applied for by the Company will assist in making available the next generation of instruments at a more rapid pace. The Medical Device Research Grant will allow Cell Bio-Systems to continue its research, development and complex process of studying new devices that will improve tissue management procedures, increase patient safety and decrease healthcare costs. Cell Bio-Systems is committed to the research and development of medical devices and procedures, from advancing the development of potential cures for many life-threatening and debilitating de·bil·i·tat·ing adj. Causing a loss of strength or energy. Debilitating Weakening, or reducing the strength of. Mentioned in: Stress Reduction diseases, to repair of damaged cells due to injuries, accidents, and birth defects birth defects, abnormalities in physical or mental structure or function that are present at birth. They range from minor to seriously deforming or life-threatening. A major defect of some type occurs in approximately 3% of all births. . About Cell Bio-Systems Based in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation). San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951. , Cell Bio-Systems is the exclusive licensee of two patented syringe connection products that it plans to adapt as disposable devices for liposuction Liposuction Definition Liposuction, also known as lipoplasty or suction-assisted lipectomy, is cosmetic surgery performed to remove unwanted deposits of fat from under the skin. and other Living Tissue Management(TM) procedures. The company is developing an affordable, disposable product line that will fill this void in the cosmetic surgery and living tissue marketplace. The company's patented, groundbreaking technology will increase patient safety and enhance procedural outcomes. Most notably, Cell Bio-Systems devices can be adapted for a variety of procedures, ranging from fat transfers to biopsies to stem cell research. The company ultimately will develop a complete living tissue management system. CBSI shareholders are encouraged to visit www.cellbiosystems.com and to register on the "Investor Relations Investor relations The process by which the corporation communicates with its investors. " page to receive ongoing CBSI news updates. Legal Notice Regarding Forward-Looking statements: "Forward-looking statements" as defined in the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 may be included in this news release. These statements relate to future events or our future financial performance. These statements are only predictions and may differ materially from actual future results or events. CBSI disclaims any intention or obligation to revise any forward-looking statements whether as a result of new information, future developments or otherwise. There are important risk factors that could cause actual results to differ from those contained in forward-looking statements, including, but not limited to risks associated with changes in general economic and business conditions (including in the information technology and financial information industry), actions of our competitors, the extent to which we are able to develop new services and markets for our services, the time and expense involved in such development activities, the level of demand and market acceptance of our services, and changes in our business strategies. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion